MeSH tree: G05.360.340.024.340.375.500.791
Melanoma is a type of cancer that originates from melanocytes, the cells responsible for producing skin pigment, and is known as the most lethal form of skin cancer due to its high rates of metastasis and recurrence. With ...
Oct 8, 2024
0
37
Northwestern Medicine scientists have discovered a new mechanism that controls a specialized group of T-cells, known as regulatory T-cells, and may serve as potential therapeutic targets to treat inflammatory disorders and ...
Oct 3, 2024
0
54
Most uterine cancers have excellent five-year survival rates—up to 95% for localized cancer. Serous uterine cancer is an exception, with five-year survival rates of 35% to 50% for stage 1 or 2 cancer.
Oct 1, 2024
0
33
Synapses are junctions via which neurons communicate with each other or with other types of cells. Synapses are formed throughout the course of a person's life, yet their strength and numbers change over time, a phenomenon ...
A team of scientists led by Dr. Björn von Eyss has discovered an additional control mechanism that prevents the growth of liver cancer.
Aug 29, 2024
0
33
Investigators have discovered that aberrant activation of a specific oncoprotein drives key tumor-promoting changes in the prostate tissue microenvironment during cancer progression, according to a Northwestern Medicine study ...
Aug 29, 2024
0
46
In looking for new ways to fight breast cancer, scientists from Duke-NUS Medical School have unmasked a surprising role of a protein generally associated with cancer growth. They have discovered that in estrogen receptor-positive ...
Aug 26, 2024
0
87
Recent research highlights the importance of targeted therapies for treating advanced colorectal cancer (CRC) with rare genetic variants. These mutations, often linked to poor prognosis and limited response to conventional ...
Aug 23, 2024
0
43
Our skin–the body's largest organ–provides the first line of defense against infections and many other threats to our health. Decades of research has shown that a wide range of diseases can occur, or become worse, when the ...
Aug 8, 2024
0
76
Scientists at Nagoya University in Japan have made a significant breakthrough in treating lipid disorders. They have developed a new compound, ZTA-261, which selectively binds to the thyroid hormone receptor beta (THRβ).
Aug 6, 2024
0
49
